Cargando…
Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
Charge heterogeneity profiling is important for the quality control (QC) of biopharmaceuticals. Because of the increasing complexity of these therapeutic entities [1], the development of alternative analytical techniques is needed. In this work, flow‐through partial‐filling affinity capillary electr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900010/ https://www.ncbi.nlm.nih.gov/pubmed/31560789 http://dx.doi.org/10.1002/elps.201900233 |
_version_ | 1783477259856773120 |
---|---|
author | Hutanu, Andrei Kiessig, Steffen Bathke, Andrea Ketterer, Rolf Riner, Sonja Olaf Stracke, Jan Wild, Markus Moritz, Bernd |
author_facet | Hutanu, Andrei Kiessig, Steffen Bathke, Andrea Ketterer, Rolf Riner, Sonja Olaf Stracke, Jan Wild, Markus Moritz, Bernd |
author_sort | Hutanu, Andrei |
collection | PubMed |
description | Charge heterogeneity profiling is important for the quality control (QC) of biopharmaceuticals. Because of the increasing complexity of these therapeutic entities [1], the development of alternative analytical techniques is needed. In this work, flow‐through partial‐filling affinity capillary electrophoresis (FTPFACE) has been established as a method for the analysis of a mixture of two similar monoclonal antibodies (mAbs). The addition of a specific ligand results in the complexation of one mAb in the co‐formulation, thus changing its migration time in the electric field. This allows the characterization of the charged variants of the non‐shifted mAb without interferences. Adsorption of proteins to the inner capillary wall has been circumvented by rinsing with guanidine hydrochloride before each injection. The presented FTPFACE approach requires only very small amounts of ligands and provides complete comparability with a standard CZE of a single mAb. |
format | Online Article Text |
id | pubmed-6900010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69000102019-12-20 Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals Hutanu, Andrei Kiessig, Steffen Bathke, Andrea Ketterer, Rolf Riner, Sonja Olaf Stracke, Jan Wild, Markus Moritz, Bernd Electrophoresis Part V. Proteins, Proteomics and 2D Charge heterogeneity profiling is important for the quality control (QC) of biopharmaceuticals. Because of the increasing complexity of these therapeutic entities [1], the development of alternative analytical techniques is needed. In this work, flow‐through partial‐filling affinity capillary electrophoresis (FTPFACE) has been established as a method for the analysis of a mixture of two similar monoclonal antibodies (mAbs). The addition of a specific ligand results in the complexation of one mAb in the co‐formulation, thus changing its migration time in the electric field. This allows the characterization of the charged variants of the non‐shifted mAb without interferences. Adsorption of proteins to the inner capillary wall has been circumvented by rinsing with guanidine hydrochloride before each injection. The presented FTPFACE approach requires only very small amounts of ligands and provides complete comparability with a standard CZE of a single mAb. John Wiley and Sons Inc. 2019-10-08 2019-11 /pmc/articles/PMC6900010/ /pubmed/31560789 http://dx.doi.org/10.1002/elps.201900233 Text en © 2019 The Authors. Electrophoresis published by Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Part V. Proteins, Proteomics and 2D Hutanu, Andrei Kiessig, Steffen Bathke, Andrea Ketterer, Rolf Riner, Sonja Olaf Stracke, Jan Wild, Markus Moritz, Bernd Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals |
title | Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals |
title_full | Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals |
title_fullStr | Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals |
title_full_unstemmed | Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals |
title_short | Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals |
title_sort | application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals |
topic | Part V. Proteins, Proteomics and 2D |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900010/ https://www.ncbi.nlm.nih.gov/pubmed/31560789 http://dx.doi.org/10.1002/elps.201900233 |
work_keys_str_mv | AT hutanuandrei applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals AT kiessigsteffen applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals AT bathkeandrea applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals AT kettererrolf applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals AT rinersonja applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals AT olafstrackejan applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals AT wildmarkus applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals AT moritzbernd applicationofaffinitycapillaryelectrophoresisforchargeheterogeneityprofilingofbiopharmaceuticals |